🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this signal seeking study was to determine whether treatment...
Status
Terminated
Location
St Joseph Heritage Healthcare St. Joseph Heritage
Start Date
2014-09-17
Trial ID
NCT02186821
Treatments Being Tested
A prospective open label, multicenter study to evaluate the feasibility and...
Status
Recruiting
Location
University of Alabama/Children's of Alabama
Start Date
2015-09
Trial ID
NCT02559778
Treatments Being Tested
Lung cancer is the most leading cause of cancer-related mortality worldwide...
Status
Unknown
Location
Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Start Date
2018-07-24
Trial ID
NCT03399487
Treatments Being Tested
This study assessed the safety and efficacy of LDK378 in adult patients wit...
Status
Completed
Location
University of Colorado School of Medicine Colorado Univ
Start Date
2011-01-24
Trial ID
NCT01283516
Treatments Being Tested
Novartis-sponsored, open-label, multi-center, interventional ETP to provide...
Status
No Longer Available
Location
Ironwood Cancer and Research Centers
Start Date
TBD
Trial ID
NCT01947608
Treatments Being Tested
The primary purpose of the study is to estimate the maximum tolerated dose ...
Status
Completed
Location
University of Colorado Dept. of Anschutz Cancer (3)
Start Date
2013-06
Trial ID
NCT01772797
A single-Arm, open-label, multi-center, phase I/II study in which the pharm...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-03-07
Trial ID
NCT02040870
Treatments Being Tested
The purpose of this study was to evaluate the anti-tumor activity of single...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-01-20
Trial ID
NCT02276027
This is an open label multi center trial to determine the safety and effica...
Status
Active Not Recruiting
Location
Mayo Clinic - Arizona
Start Date
2015-05-27
Trial ID
NCT02393625
Treatments Being Tested
This was a Phase Ib/II study of the ALK inhibitor ceritinib in combination ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-14
Trial ID
NCT02292550
Treatments Being Tested